BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2008
View Archived Issues
Jerini and PR collaborate on sustained-release formulations of ophthalmic drugs
Read More
BiPar Sciences expands clinical program for BSI-201 into glioblastoma multiforme
Read More
Preclinical activity of ENMD-2076 described
Read More
Galderma acquires CollaGenex
Read More
European Commission approves Effentora for breakthrough cancer pain
Read More
ChemGenex to submit rolling NDA to the FDA for omacetaxine mepesuccinate in CML
Read More
Lpath submits IND application to FDA for iSONEP in age-related macular degeneration
Read More
Jazz Pharmaceuticals' Luvox now available in the U.S. for treatment of SAD and OCD
Read More
Johnson & Johnson submits supplemental NDA for Risperdal Consta in FRBD
Read More
Isis reports additional results from phase II study of mipomersen in familial hypercholesterolemia
Read More
Medgenics to initiate phase I/II clinical trials in Israel of Epodure in anemia
Read More
Tolfenamic acid active against pancreatic cancer cells and tumors
Read More
H3 antagonists developed at Wyeth for cognitive dysfunction
Read More
Hdm2 antagonist JNJ-26854165 shows in vivo antitumor activity
Read More
Novel oral calcium receptor antagonists demonstrate bone formation activity in initial studies
Read More
HHS clears Iomai to begin phase II study of H5N1 adjuvant patch
Read More
FDA awards orphan drug designation for Rhitol in chronic GvHD
Read More
Silenor insomnia NDA accepted for filing
Read More
AnGes launches Naglazyme for mucopolysaccharidosis VI in Japan
Read More
Actemra approved in Japan to treat patients with rheumatoid arthritis
Read More
Humira approved in Japan for the treatment of rheumatoid arthritis
Read More
New therapeutic option for glaucoma reported in recent Organon patent
Read More
Recent Janssen patent discloses new therapeutic agents for benign prostatic hyperplasia
Read More
Recent Pfizer and Kyorin patents describe new agents for treating respiratory disorders
Read More